A new case series from Dr. Matthew Remz and the Fixel Institute challenges assumptions about deep brain stimulation (DBS) in DYT-11, a rare genetic movement disorder. Despite DBS’s high success rate, some patients don’t respond as expected—so the Fixel team asked why, and more importantly, what can be done? Through advanced troubleshooting and even surgical revision, they found answers that could reshape care far beyond UF Health. This is the first documented case series of its kind. 📖 Read how clinical curiosity led to breakthroughs—and what it could mean for the future of DBS: 🔗 fixel.ufhealth.org/2025/07/29/fixel-researchers-chart-new-ground-in-treating-challenging-cases-of-dyt-11 #MovementDisorders #DBS #Neurology #FixelInstitute #InnovationInCare #Dystonia #DYT11 #BrainResearch #UFHealth